UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019944
Receipt number R000021489
Scientific Title Modified Simultaneous Integrated Boost Radiotherapy for Large tumor
Date of disclosure of the study information 2016/01/10
Last modified on 2023/06/02 11:59:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Modified Simultaneous Integrated Boost Radiotherapy for Large tumor

Acronym

Modified Simultaneous Integrated Boost Radiotherapy for Large tumor

Scientific Title

Modified Simultaneous Integrated Boost Radiotherapy for Large tumor

Scientific Title:Acronym

Modified Simultaneous Integrated Boost Radiotherapy for Large tumor

Region

Japan


Condition

Condition

More than 10 cm longest diameter or 5 cm shortest diameter clinically or pathologically visible malignant tumor

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the safety and effectiveness of modified SIB (Simultaneous Integrated Boost)radiotherapy for Locally advanced malignant tumor

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

Initial tumor response
According to RECIST criteria (up to 6 months)

Key secondary outcomes

1) Toxicity
2) Local control
3) Cause specific survival rate
4) Overakk survival rate
5) QOL


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment

Interventions/Control_1

Radiotherapy
Up to tolerable dose to organ at risk
i.e., (2Gy/fr to intestine and 5Gy/fr to tumor central zone) Total 100Gy/20fr to tumor central zone and 40Gy/20fr to intestinal tract

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Histologically or clinically diagnosed malignant tumor
2. Large measurable tumor more than 10 cm longest diameter or more than 5 cm shortest diameter

Key exclusion criteria

1. Unable to obtain wrriten infromed consent
2. Unsuitable for treat due to severe co-mobidity or mental dysorder
3 Unsuitable for treatby Physicians perspection

Target sample size

15


Research contact person

Name of lead principal investigator

1st name hideya
Middle name
Last name Yamazaki

Organization

Graduate School of Medical Science,
Kyoto Prefectural University of Medicine

Division name

Department of Radiology

Zip code

602-0841

Address

465 Kajiicho Kawaramachi Hirokoji Kamigyo-ku, Kyoto

TEL

075-251-5111

Email

hideya10@hotmail.com


Public contact

Name of contact person

1st name Hideya
Middle name
Last name Yamazaki

Organization

Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Division name

Department of Radiology

Zip code

602-0841

Address

465 Kajiicho Kawaramachi Hirokoji Kamigyo-ku, Kyoto

TEL

075-251-5111

Homepage URL


Email

hideya10@hotmail.com


Sponsor or person

Institute

Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

Dept. of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto Prefectural University of Medicine

Address

Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602-8566

Tel

075-251-5111

Email

hideya10@hotmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 11 Month 25 Day

Date of IRB

2015 Year 12 Month 18 Day

Anticipated trial start date

2016 Year 01 Month 10 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 26 Day

Last modified on

2023 Year 06 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021489


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name